CD3/TCR Complex-Associated Lymphocyte Activation Gene-3 Molecules Inhibit CD3/TCR Signaling
Author:
Affiliation:
1. *Laboratoire d’Immunologie Cellulaire, Institut Gustave-Roussy, Villejuif, France; and
2. †Centre d’Etudes et de Recherche en Virologie et Immunologie, Hôpital La Pitié-Salpétrière, Paris, France
Abstract
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Link
https://journals.aai.org/jimmunol/article-pdf/161/8/4058/1095401/im209804058o.pdf
Reference23 articles.
1. Rossof, P. M., S. J. Burakoff, J. L. Greenstein. 1987. The role of the L3T4 molecule in mitogen and antigen activated signal transduction. Cell 49: 845
2. Ledbetter, J. A., C. H. June, P. S. Rabinovitch, A. Grossmann, T. T. Tsu, J. B. Imboden. 1988. Signal transduction through CD4 receptors: stimulatory Vδ inhibitory activity is regulated by CD4 proximity to the CD3/TCR receptor. Eur. J. Immunol. 144: 525
3. Bank, I., L. Chess. 1985. Perturbation of the T4 molecule transmits a negative signal to T cells. J. Exp. Med. 162: 1294
4. Farber, D. L., M. Luqman, O. Acuto, K. Bottomly. 1995. Control of memory CD4 T cell activation: MHC class II molecules on APCs and CD4 ligation inhibit memory but not naive CD4 T cells. Immunity 2: 249
5. Bruniquel, D., N. Borie, F. Triebel. 1997. Genomic organization of the human LAG-3/CD4 locus. Immunogenetics 47: 96
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dissociation of LAG-3 inhibitory cluster from TCR microcluster by immune checkpoint blockade;Frontiers in Immunology;2024-08-21
2. Expression of immune checkpoint molecules TIGIT and TIM-3 by tumor-infiltrating lymphocytes predicts poor outcome in sinonasal mucosal melanoma;Pathology - Research and Practice;2024-08
3. PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets;EMBO Molecular Medicine;2024-07-19
4. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31
5. Other Immune Checkpoint Targets of Interest;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3